Surgical robots have been around for decades. Mako has struggled to get sales and was bought by Stryker in 2013 mainly as a way for them to place more Stryker implants in knees. While there may be some minor benefits of precise measuring, the small benefits may not outweigh the costs. It’s hard to find a successful Mako program at any hospital. With daVinci, the costs increase while the benefits may not justify it. I’m all for advancing healthcare with surgical platforms, but robotic instruments are not always the answer. They still have a place in the OR… just not front and center as the public might think.